Catalyst Wire Dossier Catalyst Wire Dossier

Tixagevimab/Cilgavimab

tixagevimab and cilgavimab
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tixagevimab/Cilgavimab, covering 2023-08-08 to 2023-08-08. Get the full timeline:

Most recent: Clinical Trial Update: Study of Tixagevimab/Cilgavimab and Regdanvimab Efficacy for Treatment of COVID-19 [Phase 4]

See pricing